InventionMed Income Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2014	FY 2013
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013
Transaction-Based Revenues	3.17	0.28	0.26	0.37
Other Revenues	0.79	0.54	0.01	0.01
Revenue	3.96	0.82	0.27	0.38
Revenue Growth (YoY)	381.78%	209.81%	-30.40%	-
Cost of Revenue	0.51	0.59	0.04	0.06
Gross Profit	3.45	0.23	0.23	0.32
Selling, General & Admin	2.2	1.81	0.28	0.53
Depreciation & Amortization Expenses	0.89	0.85	0.01	0.04
Other Operating Expenses	0.09	0.05	0.06	0.01
Operating Income	0.27	-2.47	-0.12	-0.26
Interest Income	0.05	0	0	0.01
Interest Expense	-1.62	-1.54	-0.04	-0.01
Other Non-Operating Income (Expense)	0	0	8.65	2.22
Total Non-Operating Income (Expense)	-1.57	-1.53	8.6	2.22
Pretax Income	-1.3	-4	8.48	1.96
Provision for Income Taxes	-	-	0.03	0
Net Income	-1.3	-4	8.45	1.96
Minority Interest in Earnings	-	-	1.54	0.49
Net Income to Common	-1.3	-4	6.91	1.47
Net Income Growth	-	-	371.23%	-
Shares Outstanding (Basic)	21	21	21	18
Shares Outstanding (Diluted)	21	21	21	18
Shares Change (YoY)	-	-	16.85%	-
EPS (Basic)	-0.06	-0.19	0.33	0.08
EPS (Diluted)	-0.06	-0.19	0.33	0.08
EPS Growth	-	-	303.03%	-
Free Cash Flow	0.08	0.97	-0.03	0.05
Free Cash Flow Growth	-91.33%	-	-	-
Free Cash Flow Per Share	0.00	0.05	-0.00	0.00
Gross Margin	87.11%	28.53%	86.40%	84.52%
Operating Margin	6.77%	-300.56%	-45.87%	-67.98%
Profit Margin	-32.82%	-487.08%	3186.59%	514.20%
FCF Margin	2.11%	117.51%	-12.26%	13.56%
EBITDA	1.16	-1.62	-0.11	-0.22
EBITDA Margin	29.19%	-197.24%	-41.70%	-58.06%
EBIT	0.27	-2.47	-0.12	-0.26
EBIT Margin	6.77%	-300.56%	-45.87%	-67.98%
Effective Tax Rate	0.00%	0.00%	0.34%	0.00%